Edition:
United Kingdom

Akebia Therapeutics Inc (AKBA.OQ)

AKBA.OQ on NASDAQ Stock Exchange Global Market

9.28USD
20 Apr 2018
Change (% chg)

$-0.04 (-0.43%)
Prev Close
$9.32
Open
$9.29
Day's High
$9.54
Day's Low
$9.16
Volume
152,175
Avg. Vol
145,991
52-wk High
$20.25
52-wk Low
$9.04

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

People

Name Age Since Current Position

Muneer Satter

56 2012 Independent Chairman of the Board

John Butler

52 2013 President, Chief Executive Officer, Director

Jason Amello

48 2013 Chief Financial Officer, Senior Vice President, Treasurer

Nicole Hadas

44 2013 Senior Vice President, General Counsel, Secretary

Michel Dahan

38 2013 Senior Vice President and Chief Business Officer
» More People

Akebia Therapeutics Inc News

» More AKBA.OQ News